Kosan greenshoe exercised, raising size of deal to $27.5 million

By Lisa Kerner

Erie, Pa., April 4 - Kosan Biosciences Inc. said the underwriters of its public offering exercised the 100,000 share over-allotment in full, raising the size of the deal to 5.5 million shares or $27.5 million.

Kosan originally priced 5 million shares on March 29 at $5 per share for proceeds of $25 million.

Credit Suisse Securities LLC was the bookrunner and Cowen & Co., LLC acted as co-lead manager of the offering.

Kosan Biosciences is a biotechnology company located in Hayward, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.